MBRS-19. SYNERGISM OF HDAC AND PARP INHIBITORS IN MYC-DRIVEN GROUP 3 MEDULLOBLASTOMA CELLS

Por Vollmer, Johanna, Ecker, Jonas, Hielscher, Thomas, Valinciute, Gintvile, Oppermann, Sina, Peterziel, Heike, Oehme, Ina, Witt, Olaf, Milde, Till
Publicado no Neuro Oncol (2020)

MEDU-01. HDACi AND PLK1i ACT SYNERGISTICALLY IN MYC-AMPLIFIED MEDULLOBLASTOMA

Por Valinciute, Gintvile, Ecker, Jonas, Hielscher, Thomas, Schmidt, Christin, Remke, Marc, Sigismondo, Gianluca, Krijgsveld, Jeroen, Pfister, Stefan, Witt, Olaf, Milde, Till
Publicado no Neuro Oncol (2019)

MEDU-20. TARGETING OF MYC BY HDAC INHIBITION IN MYC AMPLIFIED GROUP 3 MEDULLOBLASTOMA

Por Ecker, Jonas, Oehme, Ina, Selt, Florian, Kool, Marcel, Chavez, Lukas, Hohloch, Juliane, Valinciute, Gintvile, van Tilburg, Cornelis M., Schnölzer, Martina, Warnken, Uwe, Wechsler-Reya, Robert, Pfister, Stefan M., Witt, Olaf, Milde, Till
Publicado no Neuro Oncol (2017)

MBRS-12. INTERFERENCE WITH THE FUNCTION OF MYC IN GROUP 3 MEDULLOBLASTOMA

Por Ecker, Jonas, Thatikonda, Venu, Oehme, Ina, Valinciute, Gintvile, Selt, Florian, Buhl, Juliane L, Usta, Diren, van Tilburg, Cornelis M, Herold-Mende, Christel, Schnölzer, Martina, Warnken, Uwe, Kool, Marcel, Jäger, Natalie, Pfister, Stefan M, Witt, Olaf, Milde, Till
Publicado no Neuro Oncol (2018)